Table 3. Estimated average incidence of otitis media cases and visits averted by PCVs, United States, 1997–2019*.
Measure | 1997–1999 | 2000–2009 | 2010–2019 | Cumulative |
---|---|---|---|---|
Average incidence of visits per 100 children | 78 | 59 | 46 | NA |
Expected visits† | NA | 154,269,900 | 155,511,917 | 309,781,817 |
Estimated visits | NA | 119,429,938 | 93,025,190 | 212,455,128 |
Visits averted‡ | NA | 34,839,962 | 62,486,726 | 97,326,688 |
*Values are rounded to the nearest whole numbers. PCV7 was approved for use in the United States in 2000; PCV13 was approved for use in the United States in 2010. NA, not applicable; PCV, pneumococcal conjugate vaccine; PCV7, 7-valent PCV; PCV13, 13-valent PCV. †Visits expected if PCVs had not been introduced. ‡Calculated by subtracting estimated visits from expected visits.